Loring Wolcott & Coolidge Fiduciary Advisors LLP Natera, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $9,919 - $13,685	-115 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $9,895 - $13,767	115 New	115 $13,000
Q1 2021 Apr 14, 2021	SELL	$91.47 - $124.36 $10,519 - $14,301	-115 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$66.66 - $111.74 $7,665 - $12,850	115 New	115 $11,000

Others Institutions Holding NTRA

# of Institutions

528

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

11.4M
Shares

$1.93 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

6.77M
Shares

$1.14 Billion
0.02% of portfolio
Jpmorgan Chase & CO New York, NY

4.63M
Shares

$780 Million
0.05% of portfolio
Farallon Capital Management LLC San Francisco, CA

4.56M
Shares

$768 Million
2.91% of portfolio
Fred Alger Management, LLC New York, NY

4.01M
Shares

$676 Million
2.57% of portfolio

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account